期刊文献+

侵袭性淋巴瘤18F标记的氟代脱氧葡萄糖摄取程度与Ki-67表达的相关性 被引量:11

Correlation of 18F-FDG uptake with tumor-proliferating antigen Ki-67 expression in aggressivelymphoma
原文传递
导出
摘要 目的探讨侵袭性淋巴瘤18F标记的氟代脱氧葡萄糖(18F-FDG)摄取程度与核抗原Ki-67表达的关系。方法回顾性分析77例侵袭性淋巴瘤初诊患者的18F-FDG正电子发射计算机体层摄影(PET-CT)扫描资料和免疫组化检测结果。采用最大标准摄取值(SUVmax)和平均标准摄取值(SUVave)衡量18F-FDG摄取程度。由计算机工作站获得每例患者全身病灶的SUVmax(BmSUVmax)、活检部位病灶的SUVmax(BxSUVmax)和SUVave(BxSUVave)。结果77例侵袭性淋巴瘤患者的BmSUVmax、BxSUVmax和BxSUVave分别为13.4±6.8、11.9±6.8和7.3±4.4,Ki-67表达为(61.2±20.4)%。BmSUVmax高于BxSUVmax(P〈0.001),BxSUVmax高于BxSUVave(P〈0.001)。其中BmSUVmax、BxSUVmax、BxSUVave与Ki-67表达呈正相关(P〈0.05),BmSUVmax与BxSUVmax、BxSUVmax与BxSUVave呈正相关(均P〈0.05)。弥漫大B细胞淋巴瘤的BmSUVmax、BxSUVmax与Ki-67表达无关(均P〉0.05)。结外NK/T细胞淋巴瘤(鼻型)的BmSUVmax、BxSUVmax与Ki-67表达呈正相关(均P〈0.05)。结论侵袭性淋巴瘤的18F-FDG摄取程度与Ki-67表达相关,BmSUVmax可弥补组织学活检的局限性;结外NK/T细胞淋巴瘤(鼻型)的18F-FDG摄取程度与Ki-67表达关系密切,提示18F-FDG摄取程度可能会提供预后信息并指导治疗。 Objective To investigate the correlation between 18F-FDG uptake in positron emission tomography/computed tomography imaging and tumor-proliferating antigen Ki-67 expression in aggressive lymphoma. Methods Data of 18F-FDG PET-CT imaging and immunohistochemical detection of Ki-67 expression of seventy-seven cases with initially diagnosed aggressive lymphoma were retrospectively analyzed. The intensity of 18F-FDG accumulation was determined by calculating the maximum standardized uptake value (SUVmax) and average standardized uptake value (SUVave). The average SUV at biopsy site (BxSUVave), SUVmax at biopsy site (BxSUVmax) and SUVmax at the highest tumor activity site of the body (BmSUVmax) were collected. Results The BmSUVmax, BxSUVmax, and BxSUVave were 13.4 ± 6.8, 11.9 ± 6.8 and 7.3 ± 4.4, respectively, and Ki-67 was (61.2 ± 20.4 ) % in the 77 aggressive lymphomas. The BmSUVmax was significantly higher than the BxSUVmax or BxSUVave ( P 〈 0.05 ). The BmSUVmax, BxSUVmax and BxSUVave were positively correlated with the Ki-67 expression in aggressive lymphoma (P 〈 0.05). A positive correlation was revealed between the BxSUVmax and BmSUVmax (P 〈 0.05), and between the BxSUVmax and BxSUVave ( P 〈 0.05 ). No significant correlation was found between the BmSUVmax or BxSUVmax and the Ki-67 in DLBCL (P 〉 0.05 ). A positive correlation was observed between the BmSUVmax or BxSUVmax and the Ki-67 expression in NK/T cell lymphoma ( P 〈 0.05). Conclusion The increasing trend of 18F-FDG uptake is correlated with the Ki-67 expression in aggressive lymphoma. The results of this study suggest that the metabolic information obtained by usingBmSUVmax may help to compensate the limited sampling of histological examination at the biopsy site. Significant correlation in NK/T cell lymphoma suggests that the metabolic information from positron emission tomography-computed tomography may offer a useful parameter in the prognosis and management of this disease.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2013年第5期356-360,共5页 Chinese Journal of Oncology
关键词 淋巴瘤 非霍奇金 KI-67抗原 体层摄影术 X线计算机 氟脱氧葡萄糖F18 标准化摄取值 预后 Lymphoma, non-Hodgkin Ki-67 antigen Tomography, X-ray computed Fluorodeoxyglucose F18 Maximum standardized uptake value Prognosis
  • 相关文献

参考文献17

  • 1Miller TP, Grogan TM, Dahlberg S, et al. Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non- Hodgkin's lymphomas: a prospective Southwest Oncology Group trial. Blood, 1994, 83 : 1460-1466.
  • 2Shou Y, Lu J, Chen T, et al. Correlation of fluomdeoxyglucose uptake and tumor-proliferating antigen Ki-67 in lymphomas. J Cancer Res Ther, 2012, 8:96-102.
  • 3Hofman MS, Hicks RJ. Using positron emission tomography to assess tumor proliferation in non-Hodgkin lymphoma. Leuk Lymphoma, 2010, 51:183-185.
  • 4高海燕,宋文忠,谢红军,刘浩,刘兆辉.^(18)F-FDG PET/CT SUVmax与淋巴瘤临床分期、病理分级关系的探讨[J].医学影像学杂志,2010,20(5):679-681. 被引量:11
  • 5Chihara D, Oki Y, Onoda H, et al. High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphoma. Int J Hematol, 2011, 93:502-508.
  • 6Ngeow JY, Quek RH, Ng DC, et al. High SUV uptake on FDG- PET/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG-PET/CT staging in lymphoma.Ann Oncol, 2009, 20 : 1543-1547.
  • 7Chan WK, Au WY, Wong CY, et al. Metabolic activity measured by F-18 FDG PET in natural killer-cell lymphoma compared to aggressive B- and T-cell lymphomas. Clin Nuel Med, 2010, 35 : 571-575.
  • 8Salles G, de Jong D, Xie W, et al. Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma : a study from the Lunenburg Lymphoma Biomarker Consortium. Blood, 2011, 117:7070-7078.
  • 9尹相丛,杨金平,李贵新.Ki-67抗原在非霍奇金淋巴瘤中表达的研究进展[J].医学综述,2008,14(7):1017-1019. 被引量:5
  • 10Watanabe R, Tomita N, Takeuchi K, et al. SUVmax in FDG-PET at the biopsy site correlates with the proliferation potential of tumor cells in non-Hodgkin lymphoma. Leuk Lymphoma, 2010, 51: 279-283.

二级参考文献20

共引文献58

同被引文献141

  • 1代娟娟,杨丽娟,武艳,杜静,孟凡涛,安佳佳,李晨.脂联素受体AdipoR1对肺癌细胞PC9增殖和迁移的影响[J].南京医科大学学报(自然科学版),2020,40(1):15-20. 被引量:3
  • 2罗要国,胡斌,黄诚,毛秋粉,郑艳.^(18)F-FDG 显像代谢参数与淋巴瘤Ki-67表达及临床病理特征的相关性研究[J].临床放射学杂志,2021,40(2):368-373. 被引量:3
  • 3乔文礼,赵晋华,王椿,何之彦,汪太松,邢岩.^(18)F-FDG符合探测显像与CT显像在淋巴瘤分期和疗效评价中的比较[J].中华肿瘤杂志,2007,29(7):536-539. 被引量:8
  • 4Pelosi E,Penna D,Doumukas A,et al.Bone marrow disease detection with FDG-PET/CT and bone marrow biopsy during the staging of malignant lymphoma:results from a large multicentre study[J].Q J Nucl Med Mol Imaging,2011,55(4):469-475.
  • 5Paulino AC,Margolin J,Dreyer Z,et al.Impact of PET-CT on involved field radiotherapy design for pediatric Hodgkin lymphoma[J].Pediatr Blood Cancer,2012,58(6):860-864.
  • 6Li YJ,Li ZM,Xia XY,et al.Prognostic value of interim and posttherapy 18 F-FDG PET/CT in patients with mature T-cell and natural killer cell lymphomas[J].J Nucl Med,2013,54(4):507-515.
  • 7Juweid ME,Stroobants S,Hoekstra OS,et al.Use of positron emission tomography for response assessment of lymphoma:consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma[J].J Clin Oncol,2007,25(5):571-578.
  • 8Hunt KE,Reichard KK.Diffuse large B-cell lymphoma[J].Arch Pathol Lab Med,2008,132(1):118-124.
  • 9Weiler-Sagie M,Bushelev O,Epelbaum R,et al.18F-FDG avidity in lymphoma readdressed:a study of 766 patients[J].J Nucl Med,2010,51 (1):25-30.
  • 10Cheson BD,Pfistner B,Juwei ME,et al.Revised response criteria for malignant lymphoma[J].J Clin Oncol,2007,25 (5):579-586.

引证文献11

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部